Terry Murdock
Chief Operating Officer at G1 THERAPEUTICS, INC.
Net worth: 447 716 $ as of 2024-03-30
Terry Murdock active positions
| Companies | Position | Start | End |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Chief Operating Officer | 2018-12-31 | - |
| Corporate Officer/Principal | 2017-08-02 | - |
Career history of Terry Murdock
Former positions of Terry Murdock
| Companies | Position | Start | End |
|---|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 2014-08-31 | 2017-06-30 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Operating Officer | 2000-12-31 | 2012-04-30 |
| The US Oncology Network | Corporate Officer/Principal | 1994-12-31 | 2000-12-31 |
| ERGOMED | Chief Tech/Sci/R&D Officer | - | - |
Training of Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| ERGOMED | Commercial Services |
| IQVIA HOLDINGS INC. | Health Services |
| Private companies | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| The US Oncology Network |
- Stock Market
- Insiders
- Terry Murdock
- Experience
